<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria</provider_name><provider_url>https://amaderbrahmanbaria.com/en</provider_url><author_name>Manik Hossain</author_name><author_url>https://amaderbrahmanbaria.com/en/author/manik/</author_url><title>Bangavax gets approval for human trial</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="qr1ObOMVvI"&gt;&lt;a href="https://amaderbrahmanbaria.com/en/2021/11/23/bangavax-gets-approval-for-human-trial/"&gt;Bangavax gets approval for human trial&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://amaderbrahmanbaria.com/en/2021/11/23/bangavax-gets-approval-for-human-trial/embed/#?secret=qr1ObOMVvI" width="600" height="338" title="&#x201C;Bangavax gets approval for human trial&#x201D; &#x2014; Amader Brahmanbaria - Most Reading Online Porotal In Brahmanbaria" data-secret="qr1ObOMVvI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://amaderbrahmanbaria.com/en/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://amaderbrahmanbaria.com/en/wp-content/uploads/2021/11/bangavax1-20211123215340.jpg</thumbnail_url><thumbnail_width>750</thumbnail_width><thumbnail_height>390</thumbnail_height><description>Local pharmaceutical company Globe Biotech Ltd has gotten the approval to conduct a clinical trial of its COVID-19 vaccine Bangavax on humans. Bangladesh Medical Research Council (BMRC) gave the approval, Globe Biotech Senior Manager (Quality and Regulation) Dr Mohammad told Jago News on Tuesday. Earlier on November 1, Globe Biotech submitted a report of its &hellip; Continue reading &rarr;</description></oembed>
